ProMIS Neurosciences, Inc. (PMN)
13.05
+0.32
(+2.51%)
USD |
NASDAQ |
Feb 09, 16:00
13.00
-0.05
(-0.38%)
After-Hours: 18:34
ProMIS Neurosciences EPS Diluted (Quarterly) : -5.928 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.58M |
| Total Expenses (Quarterly) | 11.58M |
| Enterprise Value | 11.97M |
| Earnings Yield | -104.0% |
| Normalized Earnings Yield | -126.89 |